Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria

被引：182

作者：

Gericke, Janine ^{[1
]}

Metz, Martin ^{[1
]}

Ohanyan, Tatevik ^{[1
]}

Weller, Karsten ^{[1
]}

Altrichter, Sabine ^{[1
]}

Skov, Per Stahl ^{[2
,3
,4
]}

Falkencrone, Sidsel ^{[3
]}

Brand, Janko ^{[5
]}

Kromminga, Arno ^{[6
]}

Hawro, Tomasz ^{[1
]}

Church, Martin K. ^{[1
]}

Maurer, Marcus ^{[1
]}

机构：

[1] Charite, Dept Dermatol Venerol & Allergy, Allergie Ctr Charite, Berlin, Germany

[2] Univ Hosp Southern Denmark, Dept Dermatol, Odense, Denmark

[3] RefLab ApS, Copenhagen, Denmark

[4] Natl Univ Copenhagen, Inst Immunol, Copenhagen, Denmark

[5] BioTeZ Berlin Buch GmbH, Berlin, Germany

[6] IPM Biotech GmbH, Hamburg, Germany

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 03期

关键词：

SKIN-TEST;

D O I：

10.1016/j.jaci.2016.07.047

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1059 / 1061

页数：4

共 8 条

[1] The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria [J].

Chang, Tse Wen ;

Chen, Christina ;

Lin, Chien-Jen ;

Metz, Martin ;

Church, Martin K. ;

Maurer, Marcus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) :337-+

[2] A SEROLOGICAL MEDIATOR IN CHRONIC IDIOPATHIC URTICARIA - A CLINICAL, IMMUNOLOGICAL AND HISTOLOGICAL-EVALUATION [J].

GRATTAN, CEH ;

WALLINGTON, TB ;

WARIN, RP ;

KENNEDY, CTC ;

BRADFIELD, JW .

BRITISH JOURNAL OF DERMATOLOGY, 1986, 114 (05) :583-590

[3] EAACI/GA2LEN task force consensus report: the autologous serum skin test in urticaria [J].

Konstantinou, G. N. ;

Asero, R. ;

Maurer, M. ;

Sabroe, R. A. ;

Schmid-Grendelmeier, P. ;

Grattan, C. E. H. .

ALLERGY, 2009, 64 (09) :1256-1268

[4] On the prediction of the human response: A recycled mechanistic pharmacokinetic/pharmacodynamic approach [J].

Meno-Tetang, GML ;

Lowe, PJ .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (03) :182-192

[5]

Metz M, 2014, ALLERGY, V69, P87

[6] Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients [J].

Platzer, MH ;

Grattan, CEH ;

Poulsen, LK ;

Skov, PS .

ALLERGY, 2005, 60 (09) :1152-1156

[7] Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials [J].

Zhao, Zuo-Tao ;

Ji, Chun-Mei ;

Yu, Wen-Jun ;

Meng, Ling ;

Hawro, Tomasz ;

Wei, Ji-Fu ;

Maurer, Marcus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (06) :1742-+

[8] The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update [J].

Zuberbier, T. ;

Aberer, W. ;

Asero, R. ;

Bindslev-Jensen, C. ;

Brzoza, Z. ;

Canonica, G. W. ;

Church, M. K. ;

Ensina, L. F. ;

Gimenez-Arnau, A. ;

Godse, K. ;

Goncalo, M. ;

Grattan, C. ;

Hebert, J. ;

Hide, M. ;

Kaplan, A. ;

Kapp, A. ;

Latiff, A. H. Abdul ;

Mathelier-Fusade, P. ;

Metz, M. ;

Nast, A. ;

Saini, S. S. ;

Sanchez-Borges, M. ;

Schmid-Grendelmeier, P. ;

Simons, F. E. R. ;

Staubach, P. ;

Sussman, G. ;

Toubi, E. ;

Vena, G. A. ;

Wedi, B. ;

Zhu, X. J. ;

Maurer, M. .

ALLERGY, 2014, 69 (07) :868-887

← 1 →